HIDA Scan (Hepatobiliary Scintigraphy): What It Shows About Your Gallbladder and Bile Ducts

Key takeaways

• The HIDA scan is a functional test of bile flow, not a picture of gallbladder anatomy.
• The HIDA scan cannot see gallstones; ultrasound (USG abdomen) remains the first test for suspected gallstones.
• A non-filling gallbladder supports acute cholecystitis, but fasting state, recent food, opioids and severe liver disease can all mimic or mask findings.
• Gallbladder ejection fraction depends heavily on the stimulation protocol used, so results must be read against the protocol of the unit performing the scan.
• Radiation dose is low but not zero, so the HIDA scan is used selectively in pregnancy, breastfeeding and children.

At a glance

Also known as

• Hepatobiliary scintigraphy
• HIDA scan / DISIDA or mebrofenin scan (named after the tracer used)
• Cholescintigraphy
• Gallbladder function scan, gallbladder ejection fraction study
• Commonly asked for in India as "gallbladder nuclear scan" or "pittashay scan" at the counter; some patients call it the "bile flow test"

What a HIDA scan is

The HIDA scan uses a radiopharmaceutical, a technetium-99m labelled iminodiacetic acid compound, that behaves much like bile. After intravenous injection, the liver takes up the tracer and excretes it into the bile. A gamma camera then records where the tracer goes: into the bile ducts, into the gallbladder, and onward into the duodenum.

Because the HIDA scan follows a physiological process, the HIDA scan answers questions about function. Ultrasound, CT and MRI answer questions about structure. The two types of test are complementary, not interchangeable.

Why a HIDA scan is done

• Suspected acute cholecystitis when ultrasound findings are equivocal and clinical suspicion remains.
• Suspected chronic acalculous gallbladder dysfunction (biliary dyskinesia): biliary-type pain with normal ultrasound.
• Suspected bile leak after cholecystectomy, liver surgery, liver transplant or abdominal trauma.
• Assessment of biliary drainage after biliary surgery, stenting or biliary-enteric anastomosis.
• Neonatal jaundice: as part of a wider work-up for suspected biliary atresia, alongside other tests.
• Suspected sphincter of Oddi or post-cholecystectomy biliary pain, in selected cases.

Who should get this test

A HIDA scan is appropriate only when a gastroenterologist, surgeon, paediatrician or hepatologist has a specific functional question. It is not a screening test and is not useful for general abdominal pain.

• Adults with right upper abdominal pain and a normal or inconclusive ultrasound, where gallbladder emptying is in question.
• Patients with suspected acute cholecystitis where ultrasound is inconclusive and a decision on surgery depends on the answer.
• Patients with bile-stained drain fluid, persistent pain or fever after gallbladder or liver surgery.
• Infants with persistent conjugated jaundice, as directed by a paediatric hepatology team.
• Patients being assessed for biliary complications after liver transplant.

Usually not appropriate: confirming known gallstones, investigating dyspepsia or reflux alone, staging tumours, or investigating chest pain. Results vary depending on individual clinical circumstances.

What a HIDA scan cannot detect or exclude

• Gallstones. The HIDA scan does not image stones. A HIDA scan cannot confirm or exclude cholelithiasis; ultrasound is the test for that.
• Anatomy. The HIDA scan gives poor anatomical detail. It cannot map a stricture, size a mass, or define ductal anatomy the way MRCP or ERCP can.
• Tumours. A gallbladder or bile duct cancer may produce a non-filling gallbladder or obstruction pattern indistinguishable from benign causes.
• Chronic cholecystitis reliably. Normal filling does not exclude chronic gallbladder inflammation.
• Pancreatic disease, peptic ulcer, liver lesions, bowel or cardiac causes of upper abdominal pain. These are outside the scope of the study.
• A normal HIDA scan is a description of what was seen, not proof that disease is absent. A normal tracer transit and a normal ejection fraction do not rule out biliary disease. If symptoms persist despite a normal result, return to your doctor for reassessment.
• In advanced liver disease, poor hepatic tracer uptake and excretion can make the study uninterpretable.

Related but different examinations

Which test comes first depends on the presentation. For acute right upper quadrant pain and suspected gallstone disease, ultrasound is usually the initial test. For suspected bile duct stones with a dilated duct, MRCP or EUS usually comes next. For suspected post-operative bile leak or for gallbladder emptying, the HIDA scan may be the more informative first choice. No single test is universally superior.

Variants of the HIDA scan

• Standard cholescintigraphy: images over roughly the first hour after injection, sometimes with delayed images up to several hours.
• CCK-augmented HIDA scan: cholecystokinin (or a fatty stimulus, where used) is given to measure gallbladder ejection fraction. Infusion rate and duration differ between units and strongly affect the result.
• Morphine-augmented HIDA scan: morphine may be given to help distinguish a truly obstructed gallbladder from delayed filling when the gallbladder has not filled on standard images.
• Phenobarbital-primed hepatobiliary scan: used in some centres in infants being investigated for biliary atresia.

These variants differ in preparation, drug exposure and risk, so safety information for one does not transfer to another.

How to prepare

Preparation is operational and varies between nuclear medicine departments. The written instructions given by the unit performing your scan take precedence over anything you read here.

• Fasting: a period of fasting is almost always required, because a recently fed gallbladder is already contracted and may not fill with tracer. Very prolonged fasting (including patients on intravenous nutrition) can also cause false non-filling, so tell the unit if you have not eaten for a long time.
• Medicines: bring a full list, including opioid painkillers, which can alter biliary tracer transit. Do not start, stop or change any prescribed medicine on your own, ask the doctor who prescribed it.
• Herbal, AYUSH and gym supplements: declare these too. Some are associated with liver injury that can affect tracer handling.
• Recent tests: mention any recent nuclear medicine scan, barium study or contrast imaging.
• Clothing: loose clothes; remove metallic items over the abdomen.
• Pregnancy or breastfeeding: inform the unit before the injection.

Diabetes on glucose-lowering treatment

Fasting while on insulin or sulfonylureas can cause hypoglycaemia. Ask the prescribing doctor in advance how to adjust timing, and request an early appointment slot. Carry a glucose source.

Pregnancy and breastfeeding

The HIDA scan uses ionising radiation and is generally avoided in pregnancy unless the clinical need is compelling. Ultrasound or MRI/MRCP are often preferred. If breastfeeding, the unit will advise on any interruption or expressing schedule.

Children and infants

Paediatric protocols use weight-adjusted tracer activity, different fasting rules and sometimes phenobarbital priming. Fasting instructions for adults must not be applied to a child.

Chronic kidney disease, heart failure and fluid restriction

If you have advanced CKD, heart failure or a prescribed fluid restriction, tell the unit before fasting or drinking instructions are given, so the protocol can be adapted safely.

Older adults

Prolonged lying still can be uncomfortable. Mention mobility problems, back pain or bladder urgency so the team can plan breaks.

What happens during the HIDA scan

• Check-in: identity, pregnancy status, fasting time and medicines are confirmed.
• Cannula and injection: an IV line is placed and the tracer is injected. Most people feel only the needle prick.
• Imaging: you lie on your back under a gamma camera. The camera does not touch you and does not enclose you like an MRI scanner. Images are recorded continuously or at intervals.
• Stimulation, if needed: CCK infusion may cause transient nausea, cramping, urge to pass stool or flushing. Tell the technologist if symptoms are severe.
• Delayed images: if the gallbladder has not filled, further images or morphine augmentation may be arranged, extending the visit.
• After: normal eating and activity are usually resumed the same day. Drink fluids as advised. If sedation was used, arrange for someone to accompany you home.

How long the HIDA scan takes

• Standard study: commonly about 1-2 hours from injection to completion.
• With CCK stimulation: typically adds roughly 30-60 minutes.
• With morphine augmentation or delayed imaging: the appointment may extend to three to four hours or occasionally longer.
• Total time in the department is longer than the scanning time because of check-in, cannulation and tracer preparation. Plan for at least half a day and ask the unit for its own estimate.

Understanding your HIDA scan report

The report describes a sequence of events rather than giving a single number in isolation. Typical elements include hepatic tracer uptake, time to visualisation of the bile ducts, whether and when the gallbladder filled, whether tracer reached the small bowel, and, if stimulation was performed, the gallbladder ejection fraction.

• Normal pattern: prompt liver uptake, biliary excretion, gallbladder filling and passage of tracer into the duodenum within the expected window for that unit's protocol.
• Non-visualisation of the gallbladder: supports cystic duct obstruction and, in the right clinical setting, acute cholecystitis. It is not by itself a diagnosis.
• No tracer reaching the bowel: suggests bile duct obstruction, which then needs anatomical imaging such as MRCP, EUS or ERCP to find the cause.
• Tracer outside the biliary tree: suggests a bile leak, often into the gallbladder bed, subhepatic space or a drain.
• Reduced gallbladder ejection fraction: may indicate impaired gallbladder emptying, but the threshold used depends on the CCK protocol, and low values also occur in people without biliary pain. Surgery decisions are not made on this number alone.
• Poor hepatic uptake: often reflects liver dysfunction or hyperbilirubinaemia rather than biliary obstruction.

Ejection fraction cut-offs and normal transit times differ between departments because they depend on the tracer, the stimulation agent and the infusion protocol. Use the reference values printed on your own report and have them interpreted by the doctor who requested the scan, in the context of your symptoms, examination and other tests. No result on this page should be used to self-diagnose.

When HIDA scan results can be misleading

Findings that can falsely suggest disease (false positive)

• Recent meal: a contracted gallbladder may not fill, mimicking cystic duct obstruction.
• Prolonged fasting or parenteral nutrition: viscous bile and sludge can block filling in a healthy gallbladder.
• Opioid analgesics: can delay tracer transit into the bowel and imitate obstruction.
• Chronic cholecystitis: may show delayed filling that is misread as acute disease without delayed or morphine-augmented images.
• Rapid CCK infusion: can provoke spasm and an artificially low ejection fraction; nausea alone may also reduce measured emptying.
• Bowel or renal tracer activity overlying the gallbladder bed: may be mistaken for a leak.

Findings that can falsely appear reassuring (false negative)

• Partial cystic duct obstruction: the gallbladder may still fill despite significant disease.
• Intermittent stone obstruction: may have moved on by the time of the scan.
• Small or slow bile leak: may not be captured if imaging stops too early.
• Normal ejection fraction with real biliary pain: occurs, and does not exclude gallbladder disease.

Results that may be uninterpretable

• Marked hyperbilirubinaemia or advanced cirrhosis: the liver may not concentrate and excrete enough tracer.
• Recent biliary intervention or stent: altered drainage changes expected patterns.
• Movement, vomiting or inability to lie still: degrades image quality.

Risks and safety

Different components of the study carry different risks, so they are listed separately.

The radiotracer

The tracer dose is small and is given once. Allergic reactions to IDA radiopharmaceuticals are rare. The main consideration is exposure to ionising radiation, which is low but not zero; the justification is that the information gained should outweigh that exposure. Discuss cumulative exposure with your doctor if you have had several recent scans.

CCK (cholecystokinin) stimulation

CCK commonly causes transient abdominal cramping, nausea, urge to defaecate, flushing or dizziness during infusion. These usually settle within minutes of stopping the infusion. Tell the staff immediately if symptoms are severe.

Morphine augmentation

Morphine can cause drowsiness, nausea, itching, low blood pressure or respiratory depression, and is used with caution in older adults, in respiratory disease and in anyone with opioid sensitivity. Monitoring is standard when morphine is used.

IV cannulation

Minor bruising, local pain or, uncommonly, phlebitis or tracer extravasation at the injection site.

Radiation protection after the scan

Residual tracer clears through bile and urine over hours. Units routinely advise fluid intake and simple hygiene measures, and give specific guidance to breastfeeding mothers and to those who care for young children. Results and recovery vary depending on individual clinical circumstances.

Special situations

Pregnancy

Ultrasound is the usual first-line test for biliary disease in pregnancy, with MRI/MRCP considered when more information is needed. A HIDA scan is generally deferred unless there is no adequate alternative and the clinical need is urgent; the decision involves the obstetric and radiology teams together.

Breastfeeding

Breastfeeding can usually continue with unit-specific timing advice. Expressing milk in advance may be suggested. Follow your nuclear medicine department's written instructions.

Children and neonates

In infants with prolonged conjugated jaundice, hepatobiliary scintigraphy is one part of a work-up that also includes blood tests, ultrasound and often liver biopsy. Non-excretion is suggestive but not diagnostic of biliary atresia, and excretion does not exclude all biliary disease. Time-critical referral to a paediatric hepatology unit matters more than any single scan.

Older adults

Acute cholecystitis in older adults may present with little pain and no fever, so scans are interpreted alongside a low threshold for clinical concern. Morphine augmentation is used cautiously.

Diabetes

Autonomic neuropathy and long-standing diabetes can alter gallbladder emptying, which affects ejection fraction interpretation. Fasting needs planning if you take insulin or sulfonylureas, speak to your prescriber.

Chronic kidney disease and heart failure

The tracer is cleared mainly through bile, so kidney impairment is not usually a barrier. Fluid advice after the scan must be reconciled with any prescribed fluid restriction.

Advanced liver disease

High bilirubin levels reduce tracer uptake and excretion, and the study may be non-diagnostic. Alternative imaging is often chosen.

After cholecystectomy

There is no gallbladder to assess, so the HIDA scan is used in this group mainly to look for bile leak or to assess biliary drainage, not ejection fraction.

HIDA scan in the Indian context

• Availability. Hepatobiliary scintigraphy needs a licensed nuclear medicine department with a gamma camera and an in-date radiopharmaceutical supply. These are concentrated in larger cities and tertiary hospitals, so appointments often depend on tracer delivery schedules rather than on camera time. Radiation facilities operate under AERB licensing.
• Gallstone disease patterns. Gallstone disease is common in India, with a well-recognised higher burden in the northern and north-eastern states compared with the south. Because stones are frequent, ultrasound usually answers the clinical question first, and the HIDA scan is reserved for the smaller group with functional questions.
• Terminology at the counter. The request may be written as HIDA scan, cholescintigraphy, DISIDA scan or mebrofenin hepatobiliary scan. All refer to the same family of studies. Your ultrasound report may be labelled "USG abdomen" or "sonography", and your liver blood tests may report SGPT and SGOT rather than ALT and AST.
• Coexisting liver disease. Hepatitis E, anti-tubercular therapy hepatotoxicity, and liver injury linked to herbal, AYUSH or gym supplements are all relevant local causes of jaundice and raised bilirubin that can make a hepatobiliary scan hard to interpret. Declare every product you take, prescribed or not.
• Metabolic risk at lower BMI. South Asians develop metabolic disease, including steatotic liver disease (MASLD), at lower body mass index than many other populations, so a "normal-weight" patient can still have significant liver or biliary disease.
• Data privacy. Any hospital form, app or online booking tool handling your scan details is subject to the Digital Personal Data Protection Act 2023. Ask how your images and reports are stored and shared.

Cost and insurance in India

Costs differ widely between cities, between government and private facilities, and between standard and augmented protocols. Rather than quoting a figure, ask for a written estimate that names the protocol before you book.

• What drives the price: the radiopharmaceutical dose and its transport, whether CCK or morphine augmentation is added, the number of imaging sessions and delayed images, whether SPECT or SPECT/CT is performed, sedation in children, day-care bed charges, and the nuclear medicine physician's reporting fee.
• City and sector: metro private hospitals generally charge more than smaller centres; government and teaching hospitals are usually least expensive but may have waiting lists.
• Add-on costs: consultation, blood tests, ultrasound, and any follow-on MRCP or ERCP are billed separately.
• Insurance: outpatient diagnostic scans are often not covered unless the policy has an OPD benefit, whereas the same scan during an admitted stay or approved day-care procedure is more commonly reimbursed. Cover under government schemes such as Ayushman Bharat PM-JAY depends on the package and the empanelled hospital.
• Before you pay: confirm pre-authorisation requirements, whether the tracer is billed separately, and the cancellation policy, tracer is ordered patient-specific and may be non-refundable.

Any cost figure you find online is indicative only and not a quotation. Confirm current charges directly with the facility performing the scan.

Myths and facts

Frequently asked questions

Does a HIDA scan show gallstones?

No. The HIDA scan tracks bile movement and cannot image stones. If stones are the question, ultrasound of the abdomen is the appropriate test, with EUS or MRCP used when bile duct stones are suspected and ultrasound is inconclusive. The two tests are often used together.

Is the HIDA scan painful?

Imaging under the gamma camera is painless and the camera does not touch you. You will feel the cannula being inserted. If cholecystokinin is given, transient cramping, nausea or an urge to pass stool are common and usually settle within minutes of stopping the infusion.

How long will I be in the department?

Scanning typically takes about one to two hours. With CCK stimulation, morphine augmentation or delayed images, the visit can extend to three to four hours or longer. Registration, cannulation and tracer preparation add further time, so plan for at least half a day.

How long do I need to fast?

Fasting is almost always required so the gallbladder is not already contracted, but the exact duration is set by each nuclear medicine unit. Follow the written instructions given to you. If you take insulin or sulfonylureas, ask your prescriber how to manage the fasting period safely.

Can I drive and return to work afterwards?

Most people resume normal eating, driving and work the same day. If morphine or sedation was used, you should not drive and should be accompanied home. Fluid intake advice is given at discharge and should be adjusted if you have a prescribed fluid restriction.

Is the radiation from a HIDA scan harmful?

The dose is small and given once, and the exposure is justified only when the information is expected to change management. It is not zero risk, so the scan is used selectively in pregnancy, in children and in people who have had several recent nuclear or CT studies. Discuss cumulative exposure with your doctor.

What happens if my scan suggests a blocked bile duct?

Because the HIDA scan cannot show the cause or exact site, anatomical follow-up is usually arranged, commonly MRCP or endoscopic ultrasound, with ERCP if an intervention such as stone removal or stenting is likely. Your treating doctor decides the sequence based on your symptoms and blood results.

Why did my report not mention an ejection fraction?

Gallbladder ejection fraction is only calculated when a stimulation agent such as cholecystokinin is given as part of the protocol. If the clinical question was acute cholecystitis, bile leak or biliary drainage, stimulation is often not performed, so no ejection fraction figure appears.

My HIDA scan was normal but the pain continues. What next?

A normal result describes what was seen, not what exists. Persistent biliary-type pain warrants reassessment, which may include repeat or different imaging, gastroscopy, tests for peptic ulcer or pancreatic disease, and review of medicines and supplements. Return to the doctor who requested the scan.

Sources

• Society of Nuclear Medicine and Molecular Imaging, procedure standard/practice guideline for hepatobiliary scintigraphy
• European Association of Nuclear Medicine, practice guideline on hepatobiliary scintigraphy
• American College of Radiology, Appropriateness Criteria, right upper quadrant pain
• Tokyo Guidelines for the management of acute cholecystitis and acute cholangitis
• North American Society for Pediatric Gastroenterology, Hepatology and Nutrition / ESPGHAN guidance on the evaluation of cholestatic jaundice in infants
• Atomic Energy Regulatory Board (India), regulatory framework for medical use of radiation
• Rinella ME et al. Multi-society Delphi consensus on new fatty liver disease nomenclature (steatotic liver disease, MASLD, MetALD, MASH), 2023
• Digital Personal Data Protection Act, 2023 (India)